Metabolic Effects of Quetiapine and the Modulation Role of Silymarin in Schizophrenia Patients
碩士 === 臺北醫學大學 === 藥學系 === 94 === Long-term use atypical antipsychotics, such as quetiapine (QTP), may cause weight gain, glucose dysregulation, and hepatic dysfunction. Silymarin (SB) is a commercially available product in drug stores and may be used as a dietary supplement. Even though silymarin...
Main Authors: | Shu-Huey Huang, 黃淑慧 |
---|---|
Other Authors: | Tzu-Hua Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/36747642498315685727 |
Similar Items
-
Comparison of tolerability between quetiapine and haloperidol in schizophrenia
by: Naba Raj Koirala, et al.
Published: (2012-12-01) -
The management of schizophrenia: focus on extended-release quetiapine fumarate
by: Peuskens J
Published: (2011-09-01) -
Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
by: Mitesh Kumar, et al.
Published: (2017-01-01) -
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
by: El-Khalili N
Published: (2012-11-01) -
Effects of Silymarin on Hyperglycemia
by: Chein-Yu Huang, et al.
Published: (2005)